There is a loss of time for patient care and a huge increase in time burden outside the visit for doctors and pharmacists. Another major insurance change coming next year will affect another large swath of Dushays patients: In January, BCBS Massachusetts will be excluding all GLP-1s from coverage for treatment of obesity, reserving coverage for these drugs only when indicated to treat type 2 diabetes
The TRIUMPH-3 program assesses long-term cardiovascular impact through MACE endpoints
Some experts caution that a clear causal link has not yet been established between the medication and these mental health issues, but in my view whether its causation or correlation doesnt really matter
These are some of the thinnest needles available in medicine
Hayashi, N., Iida, T., et al
In psoriasis, GLP-1 RAs, particularly liraglutide, have been associated with improvements in the Psoriasis Area and Severity Index (PASI) and Dermatology Life Quality Index (DLQI), especially among patients with T2D